RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-1100
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1411100; Gene model (P.falciparum): PF3D7_1312600; Gene product: 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, putative (BCKDHA; BCKDH-E1a)
Phenotype Asexual bloodstage; Gametocyte/Gamete; Fertilization and ookinete; Oocyst; Sporozoite;
Last modified: 26 July 2014, 15:13
  *RMgm-1100
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25032958
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA GFP-con clone 2.3.4
The mutant parasite was generated by
Name PI/ResearcherOppenheim, RD; Soldati-Favre, D
Name Group/DepartmentDepartment of Microbiology and Molecular Medicine, Faculty of Medicine
Name InstituteUniversity of Geneva
CityGeneva
CountrySwitzerland
Name of the mutant parasite
RMgm numberRMgm-1100
Principal namePbe1a_ko
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageStrongly reduced growth of asexual blood stages. Evidence is presented that parasites can only develop into mature schizonts in reticulocytes and not in normocytes
Gametocyte/GameteLower production of male and female gametocytes. Reduced exflagellation of male gametocytes.
Fertilization and ookineteLower production of male and female gametocytes. Reduced exflagellation of male gametocytes.
Reduced ookinete production
OocystReduced ookinete production
Reduced oocyst production
Aberrant formation of oocysts: reduced size and absence of sporogony (sporozoite formation)
SporozoiteReduced ookinete production
Reduced oocyst production
Aberrant formation of oocysts: reduced size and absence of sporogony (sporozoite formation)
Absence of salivary gland sporozoites
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of BCKDH and expresses GFP throughout the life cycle

Protein (function)
The mitochondrial tricarboxylic acid (TCA) cycle is one of the core metabolic pathways of eukaryotic cells, which contributes to cellular energy generation and provision of essential intermediates for macromolecule synthesis. Apicomplexan parasites possess the complete sets of genes coding for the TCA cycle. However, they lack a key mitochondrial enzyme complex that is normally required for production of acetyl-CoA from pyruvate, allowing further oxidation of glycolytic intermediates in the TCA cycle.
In this paper evidence is presented that  P. bergei utilize a second mitochondrial dehydrogenase complex, BCKDH, that is normally involved in branched amino acid catabolism, to convert pyruvate to acetyl-CoA and further catabolize glucose in the TCA cycle. BCKDH therefore functionally replaces mitochondrial PDH

Genomic and biochemical studies have shown that apicomplexan parasites target their single canonical pyruvate dehydrogenase complex (PDH) to the apicoplast, a non-photosynthetic plastid organelle involved in fatty acid biosynthesis, rather than to the mitochondrion
The absence of a mitochondrial PDH complex in these parasites suggested that glycolytic pyruvate was not converted to acetyl-CoA in the mitochondrion and further catabolised through the TCA cycle
In other organisms, lipids and branched chain amino acids (BCAA) can be catabolised in the mitochondrion to generate acetyl-CoA via pathways not dependent on PDH. However, Plasmodium spp. lack the enzymes needed for the β-oxidation of fatty acids and BCAA degradation. Together, these studies suggested that there was minimal synthesis and catabolism of acetyl-CoA in the mitochondrion. Several studies have recently led to a reappraisal of this model of carbon metabolism in Apicomplexa. These studies suggest that the translocation of the conventional mitochondrial PDH to the apicoplast was associated with a new enzyme activity that functionally replaced PDH in regulating TCA cycle metabolism.
The genomes of the apicomplexan parasites that contain a functional mitochondrion encode all of the subunits of the BCKDH (branched chain ketoacid dehydrogenase) complex, which include the branched chain α-keto acid dehydrogenase E1 subunits
The eukaryotic BCKDH and PDH complexes share many structural and enzymatic properties, catalysing analogous reactions in central carbon metabolism where the initial α-ketoacid is decarboxylated by the E1 subunit - a thiamine diphosphate (TPP)-dependent heterotetramer consisting of two α subunits (E1a) and two β subunits (E1b)
In this paper evidence is provided that BCKDH primarily fulfils the function of mitochondrial PDH in  P. berghei,

Phenotype
Strongly reduced growth of asexual blood stages. Evidence is presented that parasites can only develop into mature schizonts in reticulocytes and not in normocytes, indicating that a functional BCKDH complex is required for the development of P. berghei in mature erythrocytes.
Mutants show also reduced gametocyte production, exflagellation, ookinete and oocyst production. Oocysts show reduced size and absence of sporogony (sporozoite formation).
In this paper evidence is provided that BCKDH primarily fulfils the function of mitochondrial PDH in  P. berghei,

Additional information
Evidence is presented that parasites lacking the BCKDH-E1a subunit exhibit a perturbed TCA cycle.

Other mutants
RMgm-1101: A mutant in which the endogenous bckdh gene is replaced by the P. falciparum bckdh gene


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1411100
Gene Model P. falciparum ortholog PF3D7_1312600
Gene product2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, putative
Gene product: Alternative nameBCKDHA; BCKDH-E1a
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1GGCGGTACCCTGTAATGTAACCATCGGTGATACG
Additional information primer 1
Sequence Primer 2GGGCCCCAAATTTTTGCAAAGTGTTCATCATG
Additional information primer 2
Sequence Primer 3GGCGGATCCCACGATGAGGTAAAAGAGATGATCG!
Additional information primer 3
Sequence Primer 4GATATCGAAAATTAGTTTGAATTCCCTTGATACTG!
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6